Attached files
| file | filename |
|---|---|
| EX-99.1 - UNAUDITED PRO FORMA CONDENSED STATEMENT OF OPERATIONS OF THE COMPANY - Vystar Corp | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported) | June 1, 2016 |
VYSTAR CORPORATION
(Exact name of registrant as specified in its charter)
| Georgia | 000-53754 | 20-2027731 |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |
| 2480 Briarcliff Rd NE, #6, Suite 159, Atlanta, GA | 30329 |
| (Address of principal executive offices) | (Zip Code) |
| Registrant’s telephone number, including area code | (866) 674-5238 |
| (Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a- 12 under the Exchange Act (17 CFR 240.14a- 12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.01 Completion of Acquisition or Disposition of Assets.
Effective June 1, 2016, the Company closed its Kiron Clinical Sleep Lab, LLC division (“Kiron”) in Durham, NC.
Item 9.01 Financial Statements and Exhibits.
(b) Pro Forma Financial Information
Unaudited pro forma condensed statement of operations of the Company as of and for the three month period ended March 31, 2016 and for the fiscal year ended December 31, 2015, and unaudited balance sheet for the three month period ended March 31, 2016 and for the fiscal year ended December 31, 2015, giving effect to the disposition of Kiron, are filed as Exhibit 99.1 to this Current Report on Form 8-K/A.
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VYSTAR CORPORATION | |||
| August 19, 2016 | |||
| By: | /s/ William R. Doyle | ||
| William R. Doyle | |||
| President, Chief Executive Officer, Chief Financial Officer and Director | |||